Navigation Links
Amylin Pharmaceuticals to Present at the 18th Annual Credit Suisse Healthcare Conference
Date:11/5/2009

SAN DIEGO, Nov. 5, 2009 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will be presenting at the 18th Annual Credit Suisse Healthcare Conference in Phoenix, Arizona on Wednesday, November 11, 2009 at 10:00 a.m. PT / 1:00 p.m. ET. Mark Foletta, senior vice president of finance and chief financial officer at Amylin Pharmaceuticals, will be providing a corporate overview.

The audio portion of the presentation will be webcast and a recording will be made available following the event. The webcast and recording will be accessible through Amylin's corporate Web site, located at www.amylin.com. To access the live webcast, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company dedicated to improving lives of patients through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN® (pramlintide acetate) injection and BYETTA® (exenatide) injection. Amylin's research and development activities leverage the Company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is headquartered in San Diego, California. Further information about Amylin Pharmaceuticals is available at www.amylin.com.

SOURCE Amylin Pharmaceuticals, Inc.


'/>"/>
SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
2. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
3. Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
4. Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
5. Amylin Pharmaceuticals Reports Third Quarter Financial Results
6. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
7. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...wswire/--PraxisElectronicMedicalRecordsreceivedfir...ans,(AAFP)FamilyPracticeManagement(FPM)2009EHRUser...hmaintenance,anddiseasemanagement,allcriticalforne...ctorsindicatingtheirEMRhadapositiveeffectindetermi...nthecountryinprovidingexcellenttrainingandsupport....
(Date:11/25/2009)...e-FirstCall/--ERT(Nasdaq: ERES ),announcedtodaytha...andKeithSchneck,theCompany,sExecutiveVicePresident...ffrayHealthCareConferenceat1:30PMESTonDecember1,20...yaccessthepresentationbyvisitingtheCompany,scorpor...beaccessedat http://www.corporate-ir.net/ireye/con...
(Date:11/25/2009)...wire-USNewswire/--RemediumTechnologiesInc.,acompan...eeding,wonfirstprizeand$10,000intheMostPromisingSe...,companyofficialsannouncetoday. ,, Selectedfrom...mpitchedtheirinventionattheGSCSecuritySummitconfer...m( www.remediumtechnologies.com )isdevelopingahigh...
Breaking Medicine Technology:Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3CEO of Burrill 26amp 3B Company to Speak at BioConference Live Slated for November 17th and 18th 14305 1CEO of Burrill 26amp 3B Company to Speak at BioConference Live Slated for November 17th and 18th 14305 2CEO of Burrill 26amp 3B Company to Speak at BioConference Live Slated for November 17th and 18th 14305 3Boston Biotech R 26amp 3BD Conference to Showcase Next Generation Newsmakers and Massachusetts as Leader in Biotech Discovery 58584 1Boston Biotech R 26amp 3BD Conference to Showcase Next Generation Newsmakers and Massachusetts as Leader in Biotech Discovery 58584 2Boston Biotech R 26amp 3BD Conference to Showcase Next Generation Newsmakers and Massachusetts as Leader in Biotech Discovery 58584 3Nicole Sullivan Joins Jenny Craig to Reclaim Her Pre Baby Body 58582 1Nicole Sullivan Joins Jenny Craig to Reclaim Her Pre Baby Body 58582 2
...Mass., May 16 BioVex Inc, a biotechnology,company...d infectious,disease, announced today that the abs...e II clinical trial of OncoVEX GM-CSF in advanced ...an Society of Clinical Oncology,(ASCO) website loc...stract,which describes the data as of the submissi...
... N.J., May 16 Veridex, LLC announced today that,i...of America Holdings,(LabCorp), has commercially la...ncer. The new assay uses the biological specificit...ng the methylation of the gene,GST-Pi. Methylation...,cancer. Veridex is developing the methylation mar...
Other Medicine Technology:BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 2BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in Metastatic Melanoma at the 2008 American Society of Clinical Oncology Meeting 3
(Date:11/26/2009)... Dr. David Kim of the Live Life Again Ce...Dallas , is one of a growing number of physicians ...king sites to connect with individuals who are int... morbid obesity. Dr. Kim is utilizing Facebook to ...t his practice with the community. , ...
(Date:11/25/2009)...inn.,Nov.25/PRNewswire-USNewswire/--Whenmostpeople...opractorcanalsogivepatientsthehelptheyneed.TMJstan...aw(mandible)contacts/connectswithyourskull(tempora...MJdysfunctionarepainwithchewing,clickingorpoppingo...unctionincluding:headaches,fatigue,sleepdisturbanc...
(Date:11/25/2009)...,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleading...onsoftwarelaunchesasuiteofnewleadingedgeclinicalap...formatthisyear,sRadiologicalSocietyofNorthAmerica(...h5800,HallA).Theapplicationsleveragetheuniquehighq...magingcoilsandsupportmultipleimagingmodalitiesform...
(Date:11/25/2009)...CISCO,Nov.25/PRNewswire/--TheBayAreaAirQualityMana...Spare the Air Alert forThursday,Novembe...ranyothersolidfuel,bothindoorsandoutdoors. ,, "...tytomorrow,"saidJackBroadbent,executiveofficerofth...thehealthoftheirneighborsandfellowcommunitymembers...
(Date:11/25/2009)...s discovery that grew out of a collaboration betwe... offer hope to the nearly 10 million Americans who...Also known as hardening of the arteries, periphera...y problem in which narrowed arteries reduce blood ...ed flag for vascular disease, heart attack and str...
Breaking Medicine News(10 mins):Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4
...n outbreak of exotic sugar cane disease the Queens...arantined a farm near // Childers, south-west of B...ed what the disease is, it claims that the potenti...ace-forward process and would also begin surveilla...
...ng who is pursuing her studies at London's Brunel ...en to take their contraceptive pills //. She says ...revent unwanted pregnancies. It also advises user...rchers have found that 70% of women forget to take...
...hat is synthesized by a cancer-causing virus enabl...ne cells. This mechanism uses an unusual gene and ... // The study examines the function of a pro... The findings indicate that HBZ enhanced the abili...
...ne 10. Evolution of new methods of treatment in U... International conference and live workshop on Uro...t begins here on June 16. // A live televised...orters about the three-day conference, Dr N Rajama...
...une 11 An outbreak of measles in the US city of Bo...ammer who came from India in April to work for a f... have been identified and the authorities are taki...ogrammer who came from India on April 26 showed fi...
...o the minister of Health Manto Tshabalala-Msimang ...be recognised in the department of health's budget... in Benoni in which she said that she would set up...h the allocation of money. She said that there is ...
Other Medicine News:Health News:Cancer-Causing Virus Synthesizes Protein To Help Sustain Itself In Host Cells 2Health News:Cancer-Causing Virus Synthesizes Protein To Help Sustain Itself In Host Cells 3
3M™ Precise™ Vista Disposable Skin Stapler
...he Eppendorf Reference Series 2000 Pipette is a sy...ompact and robust design, and superior operating c... to operate the measuring stroke and blow-out as w...pipette/tip" system ensures utmost accuracy and pr...
Pipetman F200
Ovation BioNatural Pipette, two-stroke, fixed volume, 100L
Medicine Products: